DGX vs. PODD: Quest Diagnostics vs. Insulet Stock Comparison
How do Quest Diagnostics (DGX) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Quest Diagnostics (DGX) and Insulet (PODD) both fall under the Health Care Equipment & Services industry group, but DGX is classified in Health Care Providers & Services while PODD is classified in Health Care Equipment & Supplies.
| Profile Item | DGX | PODD |
|---|---|---|
| Name | Quest Diagnostics Incorporated | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 28.21 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | December 17, 1996 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DGX | PODD |
|---|---|---|
| Total Return (1Y) | 45.88% | -53.25% |
| Total Return (3Y, Annualized) | 27.45% | -0.74% |
| Total Return (5Y, Annualized) | 14.84% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DGX | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 24.06% | 46.33% |
| Beta (5Y) | 0.54 | 1.04 |
| Max Drawdown (5Y) | -28.62% | -63.02% |
| Avg. Volume (3M) | 1.00M | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DGX | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | 1.73 | -1.24 |
| Sortino Ratio (1Y) | 3.16 | -1.51 |
Profitability
ROE (TTM)
Both Quest Diagnostics (DGX) at 15.32% and Insulet (PODD) at 28.94% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Quest Diagnostics (DGX) at 9.54% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Quest Diagnostics (DGX) at 15.63% and Insulet (PODD) at 22.54% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DGX | PODD |
|---|---|---|
| ROE (TTM) | 15.32% | 28.94% |
| ROA (TTM) | 6.61% | 11.40% |
| Net Margin (TTM) | 9.54% | 13.44% |
| Operating Margin (TTM) | 15.63% | 22.54% |
| Gross Margin (TTM) | 33.18% | 71.88% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while Quest Diagnostics (DGX) at 11.78% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
Quest Diagnostics (DGX) at 13.78% is around its peer norm for EPS growth, while Insulet (PODD) at -39.79% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | DGX | PODD |
|---|---|---|
| Revenue Growth (YoY) | 11.78% | 30.73% |
| Revenue Growth (3Y CAGR) | 3.74% | 27.54% |
| EPS Growth (YoY) | 13.78% | -39.79% |
| EPS Growth (3Y CAGR) | 3.16% | 267.70% |
Financial Strength
Current Ratio (MRQ)
Both Quest Diagnostics (DGX) at 1.70 and Insulet (PODD) at 2.51 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Quest Diagnostics (DGX) at 0.80 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DGX | PODD |
|---|---|---|
| Current Ratio (MRQ) | 1.70 | 2.51 |
| Debt / Equity (MRQ) | 0.80 | 0.66 |
| Net Debt / EBITDA | 2.38 | 0.65 |
Dividends
Dividend Yield (TTM)
Insulet (PODD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a yield of 1.33%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Insulet (PODD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a payout of 25.10%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DGX | PODD |
|---|---|---|
| Dividend Yield (TTM) | 1.33% | 0.00% |
| Dividend Payout Ratio (TTM) | 25.10% | 0.00% |
Valuation
P/E Ratio (TTM)
Both Quest Diagnostics (DGX) at 25.46 and Insulet (PODD) at 23.94 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Quest Diagnostics (DGX) at 2.38 and Insulet (PODD) at 3.19 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Quest Diagnostics (DGX) at 3.68 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DGX | PODD |
|---|---|---|
| P/E Ratio (TTM) | 25.46 | 23.94 |
| P/S Ratio (TTM) | 2.38 | 3.19 |
| P/B Ratio (MRQ) | 3.68 | 6.44 |
| Free Cash Flow Yield (TTM) | 3.09% | 1.12% |